| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.911 | 0.003 | 0.911 | Aldehyde oxidase inhibitor | 0.238 0.087 CID_154699615 | ||
| 0.869 | 0.004 | 0.869 | Caspase 9 stimulant | 0.859 0.005 CID_154699615 | ||
| 0.787 | 0.004 | 0.876 | Histamine release inhibitor | 0.876 0.003 CID_154699615 | CID_154699615 | |
| 0.776 | 0.002 | 0.776 | GABA C receptor rho-3 antagonist | 0.316 0.105 CID_154699615 | ||
| 0.733 | 0.003 | 0.733 | Peroxidase inhibitor | 0.153 0.076 CID_154699615 | ||
| 0.73 | 0.005 | 0.782 | Free radical scavenger | 0.782 0.004 CID_154699615 | CID_154699615 | |
| 0.721 | 0.002 | 0.721 | Cystathionine beta-synthase inhibitor | 0.629 0.003 CID_154699615 | ||
| 0.72 | 0.004 | 0.789 | 5 Hydroxytryptamine release inhibitor | 0.789 0.003 CID_154699615 | CID_154699615 | |
| 0.711 | 0.005 | 0.827 | Antioxidant | 0.827 0.004 CID_154699615 | CID_154699615 | |
| 0.712 | 0.029 | 0.769 | Apoptosis agonist | 0.769 0.02 CID_154699615 | CID_154699615 | |
| 0.677 | 0.005 | 0.677 | Superoxide dismutase inhibitor | |||
| 0.67 | 0.005 | 0.67 | Amyloid beta aggregation inhibitor | 0.415 0.023 CID_154699615 | ||
| 0.669 | 0.009 | 0.669 | 12-Lipoxygenase inhibitor | |||
| 0.665 | 0.011 | 0.665 | Aryl hydrocarbon receptor agonist | 0.238 0.084 CID_154699615 | ||
| 0.655 | 0.017 | 0.655 | 15-Lipoxygenase inhibitor | |||
| 0.607 | 0.004 | 0.607 | Aldehyde dehydrogenase inhibitor | 0.533 0.004 CID_154699615 | ||
| 0.588 | 0.002 | 0.588 | Creatine kinase inhibitor | 0.191 0.012 CID_154699615 | ||
| 0.592 | 0.011 | 0.592 | Caspase 3 stimulant | 0.503 0.02 CID_154699615 | ||
| 0.587 | 0.016 | 0.587 | 5 Hydroxytryptamine release stimulant | 0.433 0.039 CID_154699615 | ||
| 0.563 | 0.01 | 0.563 | Calcium channel L-type activator | 0.335 0.129 CID_154699615 | ||
| 0.558 | 0.005 | 0.558 | MAO inhibitor | |||
| 0.548 | 0.004 | 0.548 | Breast cancer-resistant protein inhibitor | |||
| 0.569 | 0.035 | 0.824 | Transcription factor NF kappa B inhibitor | 0.824 0.011 CID_154699615 | CID_154699615 | |
| 0.522 | 0.005 | 0.522 | MAO A inhibitor | |||
| 0.518 | 0.003 | 0.518 | GABA C receptor rho-2 antagonist | 0.146 0.08 CID_154699615 | ||
| 0.57 | 0.061 | 0.789 | Alpha-glucosidase inhibitor | 0.789 0.019 CID_154699615 | CID_154699615 | |
| 0.513 | 0.006 | 0.704 | Melanin inhibitor | 0.704 0.003 CID_154699615 | CID_154699615 | |
| 0.503 | 0.004 | 0.503 | 5 Hydroxytryptamine uptake stimulant | 0.234 0.099 CID_154699615 | ||
| 0.515 | 0.017 | 0.515 | Lipoxygenase inhibitor | |||
| 0.508 | 0.014 | 0.546 | Hypoxia-inducible factor 1 alpha inhibitor | 0.546 0.011 CID_154699615 | CID_154699615 | |
| 0.497 | 0.004 | 0.497 | Interleukin 4 antagonist | 0.298 0.009 CID_154699615 | ||
| 0.5 | 0.008 | 0.765 | Monophenol monooxygenase inhibitor | 0.765 0.003 CID_154699615 | CID_154699615 | |
| 0.486 | 0.009 | 0.486 | P-glycoprotein inhibitor | 0.343 0.022 CID_154699615 | ||
| 0.493 | 0.016 | 0.73 | Vasodilator, coronary | 0.73 0.004 CID_154699615 | CID_154699615 | |
| 0.475 | 0.004 | 0.475 | NADPH oxidase inhibitor | 0.373 0.005 CID_154699615 | ||
| 0.474 | 0.004 | 0.644 | Xanthine oxidase inhibitor | 0.644 0.003 CID_154699615 | CID_154699615 | |
| 0.473 | 0.005 | 0.473 | Acetylcholinesterase inhibitor | 0.142 0.06 CID_154699615 | ||
| 0.467 | 0.004 | 0.467 | Estrogen receptor beta antagonist | |||
| 0.474 | 0.011 | 0.474 | Pyruvate kinase inhibitor | 0.152 0.113 CID_154699615 | ||
| 0.465 | 0.005 | 0.465 | MAO B inhibitor | |||
| 0.463 | 0.007 | 0.761 | Amylase inhibitor | 0.761 0.002 CID_154699615 | CID_154699615 | |
| 0.453 | 0.004 | 0.453 | Estrogen antagonist | 0.128 0.042 CID_154699615 | ||
| 0.449 | 0.003 | 0.449 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.121 0.029 CID_154699615 | ||
| 0.471 | 0.027 | 0.587 | Spasmolytic | 0.587 0.014 CID_154699615 | CID_154699615 | |
| 0.516 | 0.081 | 0.832 | Antiinflammatory | 0.832 0.011 CID_154699615 | CID_154699615 | |
| 0.443 | 0.01 | 0.443 | Dual specificity phosphatase inhibitor | |||
| 0.438 | 0.006 | 0.438 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.363 0.011 CID_154699615 | ||
| 0.438 | 0.009 | 0.461 | Topoisomerase II inhibitor | 0.461 0.008 CID_154699615 | CID_154699615 | |
| 0.449 | 0.022 | 0.548 | Antiamyloidogenic | 0.548 0.012 CID_154699615 | CID_154699615 | |
| 0.435 | 0.015 | 0.435 | RNA-directed DNA polymerase inhibitor | 0.369 0.022 CID_154699615 | ||
| 0.418 | 0.004 | 0.418 | Carbonic anhydrase III inhibitor | 0.246 0.01 CID_154699615 | ||
| 0.418 | 0.006 | 0.418 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.459 | 0.051 | 0.459 | Prostaglandin dehydrogenase inhibitor | |||
| 0.433 | 0.03 | 0.603 | Apoptosis antagonist | 0.603 0.009 CID_154699615 | CID_154699615 | |
| 0.424 | 0.023 | 0.598 | Nitric oxide antagonist | 0.598 0.01 CID_154699615 | CID_154699615 | |
| 0.413 | 0.012 | 0.413 | Dual specificity phosphatase 3 inhibitor | |||
| 0.397 | 0.005 | 0.397 | Topoisomerase II alpha inhibitor | 0.365 0.005 CID_154699615 | ||
| 0.417 | 0.025 | 0.75 | Hypoglycemic | 0.75 0.004 CID_154699615 | CID_154699615 | |
| 0.397 | 0.01 | 0.397 | Cholinergic | |||
| 0.39 | 0.009 | 0.474 | NOS3 expression enhancer | 0.474 0.005 CID_154699615 | CID_154699615 | |
| 0.407 | 0.027 | 0.434 | DNA damaging | 0.434 0.022 CID_154699615 | CID_154699615 | |
| 0.371 | 0.004 | 0.371 | Carbonic anhydrase VI inhibitor | 0.178 0.016 CID_154699615 | ||
| 0.364 | 0.005 | 0.364 | Carbonic anhydrase XV inhibitor | |||
| 0.369 | 0.01 | 0.517 | Protein kinase stimulant | 0.517 0.004 CID_154699615 | CID_154699615 | |
| 0.382 | 0.023 | 0.382 | Transcription factor STAT inhibitor | 0.177 0.172 CID_154699615 | ||
| 0.36 | 0.005 | 0.752 | Beta glucuronidase inhibitor | 0.752 0.002 CID_154699615 | CID_154699615 | |
| 0.382 | 0.026 | 0.482 | Vasodilator | 0.482 0.013 CID_154699615 | CID_154699615 | |
| 0.378 | 0.026 | 0.378 | Insulysin inhibitor | |||
| 0.349 | 0.004 | 0.349 | Macrophage migration inhibitory factor inhibitor | 0.069 0.067 CID_154699615 | ||
| 0.346 | 0.004 | 0.346 | Estrogen receptor alpha antagonist | |||
| 0.352 | 0.013 | 0.438 | Lipid peroxidase inhibitor | 0.438 0.008 CID_154699615 | CID_154699615 | |
| 0.411 | 0.072 | 0.69 | Antibacterial | 0.69 0.009 CID_154699615 | CID_154699615 | |
| 0.341 | 0.006 | 0.341 | Succinate dehydrogenase inhibitor | 0.183 0.065 CID_154699615 | ||
| 0.339 | 0.005 | 0.339 | Nitric-oxide synthase stimulant | 0.335 0.006 CID_154699615 | ||
| 0.334 | 0.004 | 0.334 | GABA C receptor antagonist | |||
| 0.337 | 0.008 | 0.337 | Butyrylcholinesterase inhibitor | |||
| 0.33 | 0.009 | 0.33 | Chelator | 0.113 0.06 CID_154699615 | ||
| 0.339 | 0.021 | 0.613 | Hepatoprotectant | 0.613 0.004 CID_154699615 | CID_154699615 | |
| 0.322 | 0.004 | 0.322 | Multidrug resistance-associated protein 1 inhibitor | 0.258 0.005 CID_154699615 | ||
| 0.32 | 0.003 | 0.32 | GABA C receptor rho-1 antagonist | 0.09 0.077 CID_154699615 | ||
| 0.325 | 0.015 | 0.325 | Protein-tyrosine phosphatase inhibitor | 0.261 0.028 CID_154699615 | ||
| 0.319 | 0.01 | 0.319 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.314 | 0.005 | 0.314 | Carbonic anhydrase XIII inhibitor | 0.314 0.005 CID_154699615 | ||
| 0.318 | 0.009 | 0.318 | 5-Lipoxygenase inhibitor | |||
| 0.309 | 0.005 | 0.309 | Estrogen agonist | 0.11 0.015 CID_154699615 | ||
| 0.314 | 0.01 | 0.317 | Alkaline phosphatase inhibitor | 0.317 0.01 CID_154699615 | CID_154699615 | |
| 0.328 | 0.025 | 0.508 | Platelet adhesion inhibitor | 0.508 0.005 CID_154699615 | CID_154699615 | |
| 0.317 | 0.014 | 0.321 | Neurotrophic factor enhancer | 0.321 0.013 CID_154699615 | CID_154699615 | |
| 0.346 | 0.053 | 0.346 | Calcium channel activator | |||
| 0.315 | 0.025 | 0.581 | Non-steroidal antiinflammatory agent | 0.581 0.005 CID_154699615 | CID_154699615 | |
| 0.29 | 0.004 | 0.29 | CD45 antagonist | |||
| 0.289 | 0.005 | 0.289 | Aldose reductase inhibitor | 0.235 0.005 CID_154699615 | ||
| 0.288 | 0.007 | 0.288 | Histidine decarboxylase inhibitor | |||
| 0.283 | 0.005 | 0.283 | Alcohol oxidase inhibitor | |||
| 0.282 | 0.005 | 0.282 | Uric acid excretion stimulant | 0.268 0.005 CID_154699615 | ||
| 0.284 | 0.008 | 0.639 | Mediator release inhibitor | 0.639 0.003 CID_154699615 | CID_154699615 | |
| 0.341 | 0.065 | 0.341 | Streptokinase A inhibitor | |||
| 0.278 | 0.007 | 0.278 | Telomerase inhibitor | 0.074 0.049 CID_154699615 | ||
| 0.314 | 0.047 | 0.314 | Transcription factor STAT3 inhibitor | |||
| 0.286 | 0.019 | 0.286 | Bone formation stimulant | 0.18 0.042 CID_154699615 | ||
| 0.287 | 0.021 | 0.287 | Amyloid beta precursor protein antagonist | |||
| 0.312 | 0.047 | 0.312 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.279 | 0.02 | 0.279 | Phospholipase C inhibitor | 0.215 0.035 CID_154699615 | ||
| 0.279 | 0.022 | 0.279 | Tubulin antagonist | |||
| 0.304 | 0.048 | 0.823 | Angiogenesis stimulant | 0.823 0.004 CID_154699615 | CID_154699615 | |
| 0.257 | 0.004 | 0.257 | DNA-dependent protein kinase inhibitor | |||
| 0.314 | 0.06 | 0.314 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.266 | 0.014 | 0.266 | Protein kinase (CK2) alpha inhibitor | |||
| 0.257 | 0.006 | 0.257 | Aromatase inhibitor | |||
| 0.274 | 0.024 | 0.446 | Interferon gamma antagonist | 0.446 0.009 CID_154699615 | CID_154699615 | |
| 0.326 | 0.076 | 0.602 | Cholesterol antagonist | 0.602 0.018 CID_154699615 | CID_154699615 | |
| 0.25 | 0.004 | 0.25 | Xanthine dehydrogenase inhibitor | 0.127 0.01 CID_154699615 | ||
| 0.312 | 0.069 | 0.312 | Sodium/bile acid cotransporter inhibitor | 0.223 0.158 CID_154699615 | ||
| 0.243 | 0.003 | 0.243 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.23 0.004 CID_154699615 | ||
| 0.245 | 0.005 | 0.245 | Histone deacetylase stimulant | 0.22 0.005 CID_154699615 | ||
| 0.245 | 0.005 | 0.245 | Histone deacetylase SIRT1 stimulant | 0.22 0.005 CID_154699615 | ||
| 0.255 | 0.016 | 0.255 | Protein-tyrosine phosphatase 1B inhibitor | 0.233 0.02 CID_154699615 | ||
| 0.281 | 0.042 | 0.281 | MAP kinase kinase 2 inhibitor | |||
| 0.256 | 0.022 | 0.442 | Alpha-N-acetylglucosaminidase inhibitor | 0.442 0.007 CID_154699615 | CID_154699615 | |
| 0.239 | 0.005 | 0.239 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.097 CID_154699615 | ||
| 0.237 | 0.006 | 0.237 | Electron transport complex I inhibitor | 0.124 0.042 CID_154699615 | ||
| 0.238 | 0.009 | 0.238 | Alcohol dehydrogenase inhibitor | 0.179 0.015 CID_154699615 | ||
| 0.233 | 0.004 | 0.233 | DOPA decarboxylase inhibitor | |||
| 0.277 | 0.051 | 0.427 | Cyclic AMP phosphodiesterase inhibitor | 0.427 0.013 CID_154699615 | CID_154699615 | |
| 0.285 | 0.059 | 0.528 | Tumour necrosis factor alpha release inhibitor | 0.528 0.012 CID_154699615 | CID_154699615 | |
| 0.238 | 0.015 | 0.25 | Mannose-6-phosphate isomerase inhibitor | 0.25 0.012 CID_154699615 | CID_154699615 | |
| 0.25 | 0.026 | 0.25 | Cyclooxygenase inhibitor | 0.161 0.061 CID_154699615 | ||
| 0.264 | 0.041 | 0.349 | DNA methyltransferase I inhibitor | 0.349 0.014 CID_154699615 | CID_154699615 | |
| 0.23 | 0.008 | 0.335 | Photosensitizer | 0.335 0.004 CID_154699615 | CID_154699615 | |
| 0.225 | 0.003 | 0.225 | GABA B receptor antagonist | |||
| 0.239 | 0.019 | 0.329 | Topoisomerase I inhibitor | 0.329 0.009 CID_154699615 | CID_154699615 | |
| 0.247 | 0.027 | 0.247 | Heat shock protein 90 alpha antagonist | |||
| 0.279 | 0.06 | 0.279 | Dyrk kinase inhibitor | |||
| 0.253 | 0.035 | 0.253 | Mcl-1 antagonist | |||
| 0.238 | 0.024 | 0.238 | Heat shock protein 90 antagonist | |||
| 0.222 | 0.012 | 0.222 | CF transmembrane conductance regulator agonist | 0.166 0.052 CID_154699615 | ||
| 0.217 | 0.009 | 0.217 | HIV-1 integrase (3'-Processing) inhibitor | 0.104 0.024 CID_154699615 | ||
| 0.241 | 0.033 | 0.241 | Tumour necrosis factor antagonist | |||
| 0.223 | 0.015 | 0.223 | Protein kinase (CK2) inhibitor | |||
| 0.211 | 0.004 | 0.211 | Estrogen receptor beta agonist | 0.069 0.016 CID_154699615 | ||
| 0.212 | 0.006 | 0.212 | CYP2A6 inhibitor | |||
| 0.296 | 0.09 | 0.718 | Antithrombotic | 0.718 0.007 CID_154699615 | CID_154699615 | |
| 0.23 | 0.025 | 0.23 | Cyclooxygenase 1 inhibitor | 0.141 0.062 CID_154699615 | ||
| 0.262 | 0.057 | 0.262 | Interleukin antagonist | |||
| 0.208 | 0.005 | 0.217 | Heat shock protein 70 antagonist | 0.217 0.005 CID_154699615 | CID_154699615 | |
| 0.224 | 0.021 | 0.224 | Death-associated protein kinase 2 inhibitor | |||
| 0.207 | 0.005 | 0.207 | Cyclin B3 inhibitor | |||
| 0.21 | 0.008 | 0.484 | DNA repair enzyme inhibitor | 0.484 0.003 CID_154699615 | CID_154699615 | |
| 0.205 | 0.004 | 0.205 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.222 | 0.023 | 0.367 | ATPase inhibitor | 0.367 0.004 CID_154699615 | CID_154699615 | |
| 0.216 | 0.016 | 0.412 | UDP-glucose 4-epimerase inhibitor | 0.412 0.005 CID_154699615 | CID_154699615 | |
| 0.231 | 0.036 | 0.231 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.201 | 0.007 | 0.201 | CDC25A inhibitor | 0.083 0.04 CID_154699615 | ||
| 0.207 | 0.013 | 0.207 | Potassium channel (Ca-activated) activator | |||
| 0.198 | 0.005 | 0.198 | Myeloperoxidase inhibitor | |||
| 0.236 | 0.043 | 0.236 | Insulin sensitizer | 0.228 0.049 CID_154699615 | ||
| 0.259 | 0.066 | 0.259 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.237 | 0.044 | 0.237 | I kappa B kinase epsilon inhibitor | |||
| 0.226 | 0.035 | 0.226 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.213 | 0.022 | 0.213 | Arachidonic acid antagonist | 0.152 0.086 CID_154699615 | ||
| 0.253 | 0.065 | 0.409 | DNA synthesis inhibitor | 0.409 0.02 CID_154699615 | CID_154699615 | |
| 0.188 | 0.004 | 0.188 | D-Ala-D-Ala ligase inhibitor | |||
| 0.204 | 0.022 | 0.204 | Toll-Like receptor 2 antagonist | |||
| 0.209 | 0.028 | 0.209 | Cyclooxygenase 2 inhibitor | 0.138 0.063 CID_154699615 | ||
| 0.193 | 0.012 | 0.193 | Protein kinase C zeta inhibitor | |||
| 0.194 | 0.013 | 0.194 | Porphobilinogen synthase inhibitor | |||
| 0.236 | 0.057 | 0.351 | DNA methylase inhibitor | 0.351 0.017 CID_154699615 | CID_154699615 | |
| 0.182 | 0.006 | 0.182 | Carbonic anhydrase VB inhibitor | |||
| 0.193 | 0.017 | 0.193 | Adenylate cyclase stimulant | 0.137 0.088 CID_154699615 | ||
| 0.18 | 0.004 | 0.18 | Fatty acid synthase inhibitor | 0.089 0.015 CID_154699615 | ||
| 0.186 | 0.01 | 0.186 | HIV-1 integrase (Strand Transfer) inhibitor | 0.093 0.025 CID_154699615 | ||
| 0.208 | 0.032 | 0.414 | Insulin secretagoues | 0.414 0.006 CID_154699615 | CID_154699615 | |
| 0.25 | 0.079 | 0.25 | Gastrin inhibitor | 0.214 0.128 CID_154699615 | ||
| 0.184 | 0.012 | 0.184 | Urease inhibitor | |||
| 0.178 | 0.01 | 0.178 | Keratolytic | |||
| 0.177 | 0.009 | 0.177 | Carbonic anhydrase V inhibitor | |||
| 0.172 | 0.005 | 0.172 | Protease activated receptor antagonist | |||
| 0.176 | 0.009 | 0.176 | Glutamate decarboxylase inhibitor | |||
| 0.189 | 0.022 | 0.189 | GABA C receptor agonist | |||
| 0.227 | 0.061 | 0.227 | Anesthetic general | 0.203 0.073 CID_154699615 | ||
| 0.179 | 0.016 | 0.179 | Androgen antagonist | |||
| 0.168 | 0.005 | 0.168 | Estrogen receptor alpha agonist | |||
| 0.212 | 0.053 | 0.212 | Histone acetyltransferase inhibitor | |||
| 0.195 | 0.037 | 0.195 | Neurotensin receptor agonist | |||
| 0.231 | 0.073 | 0.231 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.183 | 0.026 | 0.482 | Cyclooxygenase 3 inhibitor | 0.482 0.003 CID_154699615 | CID_154699615 | |
| 0.315 | 0.158 | 0.315 | DNA polymerase beta inhibitor | |||
| 0.169 | 0.012 | 0.184 | Thioredoxin inhibitor | 0.184 0.01 CID_154699615 | CID_154699615 | |
| 0.174 | 0.018 | 0.174 | TRPA1 agonist | 0.105 0.078 CID_154699615 | ||
| 0.186 | 0.031 | 0.364 | Alkylator | 0.364 0.009 CID_154699615 | CID_154699615 | |
| 0.267 | 0.113 | 0.267 | Thyroid hormone antagonist | |||
| 0.25 | 0.096 | 0.533 | Immunostimulant | 0.533 0.025 CID_154699615 | CID_154699615 | |
| 0.169 | 0.016 | 0.169 | Prolactin inhibitor | |||
| 0.184 | 0.031 | 0.184 | Cholesterol synthesis inhibitor | 0.133 0.054 CID_154699615 | ||
| 0.168 | 0.015 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 CID_154699615 | ||
| 0.159 | 0.009 | 0.159 | Carbonic anhydrase VA inhibitor | |||
| 0.154 | 0.005 | 0.154 | Topoisomerase II beta inhibitor | 0.111 0.008 CID_154699615 | ||
| 0.163 | 0.016 | 0.163 | Transcription factor STAT6 inhibitor | |||
| 0.153 | 0.009 | 0.153 | Thioredoxin reductase inhibitor | 0.086 0.047 CID_154699615 | ||
| 0.302 | 0.16 | 0.302 | DNA directed DNA polymerase inhibitor | |||
| 0.152 | 0.01 | 0.152 | Ornithine decarboxylase inhibitor | 0.125 0.022 CID_154699615 | ||
| 0.323 | 0.182 | 0.323 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.146 | 0.006 | 0.146 | Carbonic anhydrase VII inhibitor | 0.059 0.02 CID_154699615 | ||
| 0.185 | 0.045 | 0.343 | Hexokinase inhibitor | 0.343 0.007 CID_154699615 | CID_154699615 | |
| 0.26 | 0.12 | 0.26 | Vasodilator, peripheral | 0.239 0.136 CID_154699615 | ||
| 0.213 | 0.073 | 0.219 | Psychostimulant | 0.219 0.07 CID_154699615 | CID_154699615 | |
| 0.142 | 0.003 | 0.142 | Dopamine D5 agonist | |||
| 0.156 | 0.018 | 0.335 | Triose-phosphate isomerase inhibitor | 0.335 0.004 CID_154699615 | CID_154699615 | |
| 0.157 | 0.022 | 0.157 | Sphingomyelinase inhibitor | 0.142 0.028 CID_154699615 | ||
| 0.137 | 0.004 | 0.137 | Glutamate (mGluR7) antagonist | |||
| 0.198 | 0.065 | 0.198 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.166 | 0.036 | 0.166 | Adenylate cyclase inhibitor | 0.102 0.082 CID_154699615 | ||
| 0.249 | 0.119 | 0.249 | Thyroid hormone beta antagonist | |||
| 0.153 | 0.024 | 0.153 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.165 | 0.036 | 0.165 | Antibacterial (Helicobacter pylori) | |||
| 0.134 | 0.006 | 0.134 | Aryl hydrocarbon receptor antagonist | |||
| 0.154 | 0.026 | 0.452 | AMP-activated protein kinase stimulant | 0.452 0.004 CID_154699615 | CID_154699615 | |
| 0.295 | 0.167 | 0.826 | Cyclophilin D inhibitor | 0.826 0.005 CID_154699615 | CID_154699615 | |
| 0.138 | 0.014 | 0.138 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.143 | 0.019 | 0.276 | NADH dehydrogenase inhibitor | 0.276 0.007 CID_154699615 | CID_154699615 | |
| 0.178 | 0.055 | 0.178 | Phospholipase A2 inhibitor | 0.145 0.079 CID_154699615 | ||
| 0.158 | 0.035 | 0.186 | Beta amyloid protein antagonist | 0.186 0.022 CID_154699615 | CID_154699615 | |
| 0.134 | 0.013 | 0.134 | Potassium channel large-conductance Ca-activated activator | |||
| 0.132 | 0.011 | 0.132 | Alpha tubulin antagonist | |||
| 0.168 | 0.049 | 0.356 | Cell wall synthesis inhibitor | 0.356 0.008 CID_154699615 | CID_154699615 | |
| 0.14 | 0.024 | 0.14 | Anabolic | |||
| 0.128 | 0.011 | 0.128 | GABA receptor antagonist | |||
| 0.174 | 0.06 | 0.174 | Catenin beta inhibitor | |||
| 0.127 | 0.014 | 0.127 | mTOR complex 2 inhibitor | |||
| 0.126 | 0.013 | 0.126 | HIV-1 integrase inhibitor | |||
| 0.121 | 0.009 | 0.121 | Beta 3 adrenoreceptor antagonist | |||
| 0.119 | 0.01 | 0.119 | Estrogen-related receptor beta agonist | |||
| 0.157 | 0.049 | 0.157 | MAP kinase kinase 4 inhibitor | |||
| 0.144 | 0.036 | 0.149 | Mucolytic | 0.149 0.033 CID_154699615 | CID_154699615 | |
| 0.155 | 0.047 | 0.155 | Farnesoid X receptor antagonist | |||
| 0.12 | 0.015 | 0.12 | Leukotriene antagonist | 0.108 0.018 CID_154699615 | ||
| 0.106 | 0.005 | 0.106 | Transcription factor RelA inhibitor | |||
| 0.141 | 0.04 | 0.141 | 5 Hydroxytryptamine 3A agonist | |||
| 0.106 | 0.007 | 0.106 | Potassium channel Kv1.3 blocker | |||
| 0.14 | 0.041 | 0.14 | Interleukin 8 antagonist | |||
| 0.157 | 0.059 | 0.479 | Hemostatic | 0.479 0.005 CID_154699615 | CID_154699615 | |
| 0.121 | 0.023 | 0.121 | Interleukin 5 antagonist | 0.107 0.034 CID_154699615 | ||
| 0.11 | 0.013 | 0.11 | CDC25B inhibitor | |||
| 0.109 | 0.014 | 0.163 | Neuraminidase (influenza) inhibitor | 0.163 0.006 CID_154699615 | CID_154699615 | |
| 0.104 | 0.01 | 0.104 | MAP kinase kinase 7 inhibitor | |||
| 0.108 | 0.014 | 0.108 | Purinergic P2X1 antagonist | 0.056 0.051 CID_154699615 | ||
| 0.107 | 0.014 | 0.107 | Maillard reaction inhibitor | 0.055 0.038 CID_154699615 | ||
| 0.129 | 0.037 | 0.129 | Adenylate kinase inhibitor | 0.106 0.059 CID_154699615 | ||
| 0.096 | 0.004 | 0.096 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.112 | 0.021 | 0.112 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.117 | 0.026 | 0.215 | Phosphofructokinase-1 inhibitor | 0.215 0.01 CID_154699615 | CID_154699615 | |
| 0.133 | 0.043 | 0.381 | Expectorant | 0.381 0.005 CID_154699615 | CID_154699615 | |
| 0.1 | 0.011 | 0.143 | Carbonic anhydrase XIV inhibitor | 0.143 0.005 CID_154699615 | CID_154699615 | |
| 0.094 | 0.004 | 0.094 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.11 | 0.022 | 0.11 | Lipase inhibitor | 0.073 0.051 CID_154699615 | ||
| 0.097 | 0.011 | 0.097 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.09 | 0.005 | 0.09 | Ryanodine receptor antagonist | |||
| 0.09 | 0.005 | 0.09 | Adenylate cyclase 1 inhibitor | |||
| 0.134 | 0.05 | 0.134 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.102 | 0.019 | 0.178 | Carbonic anhydrase XII inhibitor | 0.178 0.01 CID_154699615 | CID_154699615 | |
| 0.097 | 0.016 | 0.136 | Neuraminidase inhibitor | 0.136 0.008 CID_154699615 | CID_154699615 | |
| 0.113 | 0.032 | 0.163 | Phosphodiesterase 6D inhibitor | 0.163 0.007 CID_154699615 | CID_154699615 | |
| 0.102 | 0.021 | 0.102 | Beta tubulin antagonist | |||
| 0.114 | 0.035 | 0.134 | Interleukin 12 antagonist | 0.134 0.019 CID_154699615 | CID_154699615 | |
| 0.081 | 0.003 | 0.081 | Estrogen-related receptor beta antagonist | |||
| 0.114 | 0.037 | 0.114 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.083 | 0.007 | 0.083 | Leukotriene C antagonist | 0.054 0.046 CID_154699615 | ||
| 0.117 | 0.041 | 0.174 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.174 0.02 CID_154699615 | CID_154699615 | |
| 0.101 | 0.025 | 0.101 | Leukotriene synthesis inhibitor | |||
| 0.156 | 0.08 | 0.263 | Interleukin 6 antagonist | 0.263 0.02 CID_154699615 | CID_154699615 | |
| 0.194 | 0.119 | 0.194 | Calpain inhibitor | |||
| 0.09 | 0.016 | 0.09 | Glutamate (mGluR6) antagonist | |||
| 0.092 | 0.018 | 0.092 | GABA A receptor antagonist | |||
| 0.108 | 0.035 | 0.108 | Bile acid receptor antagonist | |||
| 0.1 | 0.027 | 0.1 | GABA aminotransferase inhibitor | 0.089 0.036 CID_154699615 | ||
| 0.104 | 0.032 | 0.104 | Cathepsin G inhibitor | |||
| 0.077 | 0.007 | 0.077 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.086 | 0.017 | 0.086 | Heat shock protein 90 beta antagonist | |||
| 0.073 | 0.005 | 0.073 | Dopamine autoreceptor agonist | |||
| 0.121 | 0.052 | 0.121 | Aminopeptidase B inhibitor | |||
| 0.079 | 0.011 | 0.079 | Dihydroorotate oxidase inhibitor | |||
| 0.1 | 0.032 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.123 0.015 CID_154699615 | CID_154699615 | |
| 0.074 | 0.007 | 0.074 | Sirtuin 2 inhibitor | |||
| 0.102 | 0.035 | 0.102 | Glutathione S-transferase inhibitor | |||
| 0.193 | 0.127 | 0.329 | Interleukin agonist | 0.329 0.036 CID_154699615 | CID_154699615 | |
| 0.11 | 0.045 | 0.11 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.074 | 0.009 | 0.074 | Cholesterol esterase inhibitor | |||
| 0.069 | 0.004 | 0.069 | ATP citrate lysase inhibitor | |||
| 0.145 | 0.081 | 0.316 | Diuretic | 0.316 0.02 CID_154699615 | CID_154699615 | |
| 0.096 | 0.032 | 0.096 | Caspase 7 inhibitor | |||
| 0.107 | 0.043 | 0.281 | Antineoplastic antibiotic | 0.281 0.011 CID_154699615 | CID_154699615 | |
| 0.117 | 0.054 | 0.124 | Acetylcholine release stimulant | 0.124 0.042 CID_154699615 | CID_154699615 | |
| 0.069 | 0.007 | 0.083 | Neuraminidase (Influenza A) inhibitor | 0.083 0.005 CID_154699615 | CID_154699615 | |
| 0.121 | 0.059 | 0.165 | Microtubule formation inhibitor | 0.165 0.031 CID_154699615 | CID_154699615 | |
| 0.078 | 0.016 | 0.078 | Cyclin B2 inhibitor | |||
| 0.113 | 0.051 | 0.181 | Toll-Like receptor 4 antagonist | 0.181 0.009 CID_154699615 | CID_154699615 | |
| 0.123 | 0.063 | 0.123 | Proteasome inhibitor | |||
| 0.081 | 0.021 | 0.081 | Cyclin B1 inhibitor | |||
| 0.088 | 0.028 | 0.088 | GABA B receptor agonist | |||
| 0.064 | 0.005 | 0.064 | Protein kinase (CK2) beta inhibitor | |||
| 0.225 | 0.167 | 0.225 | Calpain 2 inhibitor | |||
| 0.081 | 0.023 | 0.081 | Androgen agonist | |||
| 0.076 | 0.019 | 0.076 | Sphingosine kinase inhibitor | |||
| 0.133 | 0.076 | 0.133 | Neurotrophic factor | 0.122 0.091 CID_154699615 | ||
| 0.106 | 0.049 | 0.106 | MAP kinase kinase 1 inhibitor | |||
| 0.086 | 0.03 | 0.086 | Dopamine D1 antagonist | |||
| 0.122 | 0.066 | 0.159 | DNA polymerase I inhibitor | 0.159 0.044 CID_154699615 | CID_154699615 | |
| 0.077 | 0.022 | 0.077 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.1 | 0.045 | 0.1 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.07 CID_154699615 | ||
| 0.078 | 0.024 | 0.078 | Protein kinase C eta inhibitor | |||
| 0.062 | 0.01 | 0.107 | Arginase inhibitor | 0.107 0.004 CID_154699615 | CID_154699615 | |
| 0.067 | 0.015 | 0.067 | CXC chemokine 1 receptor antagonist | |||
| 0.064 | 0.012 | 0.064 | Purinergic P2X4 antagonist | |||
| 0.07 | 0.019 | 0.07 | Aconitate hydratase inhibitor | |||
| 0.057 | 0.007 | 0.057 | Leukotriene C4 antagonist | |||
| 0.161 | 0.111 | 0.161 | Antimitotic | |||
| 0.111 | 0.061 | 0.111 | Ferrochelatase inhibitor | |||
| 0.056 | 0.006 | 0.056 | Estrone sulfatase inhibitor | |||
| 0.078 | 0.029 | 0.078 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.077 | 0.029 | 0.077 | Beta adrenoreceptor antagonist | |||
| 0.077 | 0.029 | 0.1 | Carbonic anhydrase IX inhibitor | 0.1 0.02 CID_154699615 | CID_154699615 | |
| 0.068 | 0.021 | 0.105 | Leukotriene B4 antagonist | 0.105 0.009 CID_154699615 | CID_154699615 | |
| 0.088 | 0.041 | 0.119 | Interferon agonist | 0.119 0.017 CID_154699615 | CID_154699615 | |
| 0.081 | 0.034 | 0.081 | Carbonic anhydrase inhibitor | 0.08 0.035 CID_154699615 | ||
| 0.135 | 0.089 | 0.135 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.062 | 0.017 | 0.091 | Glucose-6-phosphate isomerase inhibitor | 0.091 0.006 CID_154699615 | CID_154699615 | |
| 0.188 | 0.143 | 0.188 | Neuropeptide Y2 antagonist | |||
| 0.085 | 0.04 | 0.085 | Glutamate dehydrogenase inhibitor | |||
| 0.07 | 0.026 | 0.081 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.081 0.02 CID_154699615 | CID_154699615 | |
| 0.067 | 0.024 | 0.067 | Cyclin B inhibitor | |||
| 0.071 | 0.027 | 0.071 | Cyclin D1 inhibitor | |||
| 0.081 | 0.038 | 0.081 | MAP3K7 inhibitor | |||
| 0.133 | 0.09 | 0.133 | Pregnane X receptor agonist | |||
| 0.075 | 0.032 | 0.075 | NMDA receptor glycine site agonist | |||
| 0.123 | 0.081 | 0.123 | Vanilloid 1 agonist | |||
| 0.124 | 0.082 | 0.124 | Interleukin 1 antagonist | |||
| 0.05 | 0.008 | 0.05 | Vanilloid 3 antagonist | |||
| 0.079 | 0.038 | 0.079 | Dopamine agonist | |||
| 0.054 | 0.013 | 0.054 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.073 | 0.033 | 0.073 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.125 | 0.085 | 0.125 | Cytokine production inhibitor | |||
| 0.236 | 0.197 | 0.236 | Transcription factor inhibitor | |||
| 0.086 | 0.046 | 0.119 | T cell inhibitor | 0.119 0.014 CID_154699615 | CID_154699615 | |
| 0.092 | 0.054 | 0.092 | Calcium antagonist | |||
| 0.116 | 0.078 | 0.116 | MAP kinase kinase inhibitor | |||
| 0.056 | 0.018 | 0.079 | Cytokine production stimulant | 0.079 0.005 CID_154699615 | CID_154699615 | |
| 0.08 | 0.043 | 0.08 | Adenosine A3 receptor antagonist | |||
| 0.068 | 0.031 | 0.068 | Argininosuccinate synthase inhibitor | |||
| 0.05 | 0.014 | 0.05 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.074 | 0.039 | 0.074 | Protein kinase C beta inhibitor | |||
| 0.058 | 0.023 | 0.058 | Squalene epoxidase inhibitor | |||
| 0.077 | 0.042 | 0.077 | Glycine receptor agonist | 0.067 0.061 CID_154699615 | ||
| 0.045 | 0.011 | 0.045 | Catechol O-methyltransferase inhibitor | |||
| 0.055 | 0.022 | 0.055 | Dopamine D5 antagonist | |||
| 0.077 | 0.045 | 0.077 | Aminopeptidase I inhibitor | |||
| 0.06 | 0.028 | 0.06 | Sigma receptor antagonist | |||
| 0.119 | 0.087 | 0.119 | Toll-Like receptor 9 antagonist | |||
| 0.213 | 0.183 | 0.526 | Immunosuppressant | 0.526 0.026 CID_154699615 | CID_154699615 | |
| 0.06 | 0.03 | 0.06 | Pregnane X receptor antagonist | |||
| 0.057 | 0.028 | 0.114 | Glucose-6-phosphate translocase inhibitor | 0.114 0.005 CID_154699615 | CID_154699615 | |
| 0.087 | 0.058 | 0.087 | NMDA receptor antagonist | |||
| 0.101 | 0.072 | 0.187 | DNA intercalator | 0.187 0.03 CID_154699615 | CID_154699615 | |
| 0.045 | 0.016 | 0.045 | Glutamate (mGluR8) agonist | |||
| 0.047 | 0.019 | 0.047 | Progesterone antagonist | |||
| 0.071 | 0.044 | 0.071 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.121 | 0.095 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.033 | 0.007 | 0.033 | Glutamate (mGluR1a) agonist | |||
| 0.137 | 0.111 | 0.137 | Antipruritic | |||
| 0.052 | 0.027 | 0.052 | Dopamine beta hydroxylase inhibitor | |||
| 0.066 | 0.042 | 0.088 | Interferon inducer | 0.088 0.018 CID_154699615 | CID_154699615 | |
| 0.037 | 0.013 | 0.037 | Glutamate (mGluR3) agonist | |||
| 0.033 | 0.01 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.055 | 0.033 | 0.055 | NMDA 2A receptor antagonist | |||
| 0.055 | 0.033 | 0.203 | Heparanase inhibitor | 0.203 0.002 CID_154699615 | CID_154699615 | |
| 0.081 | 0.06 | 0.081 | CC chemokine 5 receptor agonist | |||
| 0.039 | 0.019 | 0.039 | RNA-directed RNA polymerase inhibitor | |||
| 0.088 | 0.068 | 0.094 | Glutamate release inhibitor | 0.094 0.052 CID_154699615 | CID_154699615 | |
| 0.081 | 0.061 | 0.081 | Inducible nitric-oxide synthase inhibitor | |||
| 0.111 | 0.092 | 0.111 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.046 | 0.026 | 0.046 | Glutamate (mGluR group III) antagonist | |||
| 0.039 | 0.02 | 0.039 | Retinoid X alpha receptor agonist | |||
| 0.062 | 0.043 | 0.062 | NMDA 2C receptor antagonist | |||
| 0.06 | 0.041 | 0.06 | Biliverdin reductase inhibitor | |||
| 0.052 | 0.034 | 0.052 | Beta 2 adrenoreceptor antagonist | |||
| 0.027 | 0.009 | 0.027 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.067 | 0.049 | 0.067 | Sirtuin 1 inhibitor | |||
| 0.041 | 0.024 | 0.041 | Retinoic acid alpha receptor agonist | |||
| 0.069 | 0.052 | 0.069 | NMDA 2 receptor antagonist | |||
| 0.073 | 0.055 | 0.079 | Phosphodiesterase VI inhibitor | 0.079 0.042 CID_154699615 | CID_154699615 | |
| 0.09 | 0.073 | 0.09 | Electrolyte absorption antagonist | |||
| 0.062 | 0.045 | 0.062 | NMDA receptor agonist | |||
| 0.044 | 0.027 | 0.044 | Heme oxygenase inhibitor | |||
| 0.04 | 0.024 | 0.04 | Retinoid X receptor antagonist | |||
| 0.04 | 0.025 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.035 | 0.019 | 0.035 | Protein kinase C beta I inhibitor | 0.031 0.03 CID_154699615 | ||
| 0.034 | 0.019 | 0.034 | HCV NS5B polymerase inhibitor | |||
| 0.022 | 0.007 | 0.036 | Antibiotic Anthracycline-like | 0.036 0.003 CID_154699615 | CID_154699615 | |
| 0.042 | 0.028 | 0.042 | Liver X receptor alpha agonist | |||
| 0.06 | 0.046 | 0.06 | Heme oxygenase stimulant | |||
| 0.037 | 0.023 | 0.037 | ATM kinase inhibitor | |||
| 0.028 | 0.015 | 0.028 | Thyroid hormone agonist | |||
| 0.089 | 0.076 | 0.089 | Alpha 2c adrenoreceptor antagonist | |||
| 0.058 | 0.046 | 0.058 | TRPA1 antagonist | |||
| 0.028 | 0.016 | 0.028 | Leukotriene D4 antagonist | |||
| 0.033 | 0.022 | 0.033 | Estrogen-related receptor alpha antagonist | |||
| 0.079 | 0.068 | 0.079 | Histamine N-methyltransferase inhibitor | |||
| 0.051 | 0.041 | 0.051 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.066 | 0.057 | 0.066 | Secretase beta inhibitor | |||
| 0.071 | 0.062 | 0.071 | Vanilloid 4 agonist | |||
| 0.027 | 0.018 | 0.112 | Sodium/glucose cotransporter 2 inhibitor | 0.112 0.002 CID_154699615 | CID_154699615 | |
| 0.051 | 0.043 | 0.051 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.033 | 0.026 | 0.033 | Retinoid X alpha receptor antagonist | |||
| 0.024 | 0.018 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.102 | 0.096 | 0.102 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.125 | 0.12 | 0.125 | MAP kinase 3 inhibitor | |||
| 0.073 | 0.068 | 0.122 | Glycine receptor antagonist | 0.122 0.017 CID_154699615 | CID_154699615 | |
| 0.017 | 0.012 | 0.017 | Nicotinic acid receptor 1 antagonist | |||
| 0.035 | 0.03 | 0.035 | Delayed rectifier potassium channel blocker | |||
| 0.064 | 0.059 | 0.064 | Exportin-1 inhibitor | |||
| 0.034 | 0.03 | 0.034 | NMDA receptor subunit 3A antagonist | |||
| 0.052 | 0.048 | 0.052 | Immunoglobulin Fc receptor antagonist | |||
| 0.024 | 0.021 | 0.098 | Sodium/glucose cotransporter inhibitor | 0.098 0.003 CID_154699615 | CID_154699615 | |
| 0.038 | 0.034 | 0.038 | Oxytocin agonist | |||
| 0.039 | 0.035 | 0.052 | Guanylate cyclase inhibitor | 0.052 0.019 CID_154699615 | CID_154699615 | |
| 0.04 | 0.036 | 0.04 | Nerve growth factor antagonist | |||
| 0.02 | 0.017 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.035 | 0.032 | 0.035 | Cathepsin L2 inhibitor | |||
| 0.02 | 0.017 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.025 | 0.023 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.048 | 0.046 | 0.048 | Carbonic anhydrase II inhibitor | |||
| 0.03 | 0.028 | 0.03 | Fumarate hydratase inhibitor | |||
| 0.016 | 0.014 | 0.023 | Telomerase stimulant | 0.023 0.005 CID_154699615 | CID_154699615 | |
| 0.017 | 0.016 | 0.017 | Estrogen-related receptor gamma agonist | |||
| 0.033 | 0.032 | 0.033 | Glutamate (mGluR3) antagonist | |||
| 0.037 | 0.036 | 0.037 | Carbonic anhydrase IV inhibitor | |||
| 0.041 | 0.04 | 0.041 | Adenosine deaminase inhibitor | |||
| 0.05 | 0.049 | 0.05 | Adenosine A1 receptor antagonist | |||
| 0.043 | 0.042 | 0.043 | Aldosterone antagonist | |||
| 0.023 | 0.023 | 0.038 | Vanilloid 2 agonist | 0.038 0.005 CID_154699615 | CID_154699615 | |
| 0.147 | 0.149 | 0.39 | Platelet antagonist | 0.39 0.029 CID_154699615 | CID_154699615 | |
| 0.047 | 0.05 | 0.1 | Alpha-mannosidase inhibitor | 0.1 0.006 CID_154699615 | CID_154699615 | |
| 0.022 | 0.026 | 0.034 | Uridine phosphorylase inhibitor | 0.034 0.015 CID_154699615 | CID_154699615 | |
| 0.119 | 0.124 | 0.154 | CC chemokine 6 receptor antagonist | 0.154 0.018 CID_154699615 | CID_154699615 | |
| 0.019 | 0.024 | 0.029 | Dopamine D1 agonist | 0.029 0.01 CID_154699615 | CID_154699615 | |
| 0.018 | 0.024 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.015 CID_154699615 | CID_154699615 | |
| 0.007 | 0.018 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_154699615 | CID_154699615 | |
| 0.017 | 0.033 | 0.072 | Protein 30S ribosomal subunit inhibitor | 0.072 0.005 CID_154699615 | CID_154699615 | |
| 0.035 | 0.052 | 0.101 | Mannosidase inhibitor | 0.101 0.005 CID_154699615 | CID_154699615 | |
| 0.042 | 0.067 | 0.056 | Factor III inhibitor | 0.056 0.023 CID_154699615 | CID_154699615 | |
| 0.049 | 0.074 | 0.071 | Lipocortins synthesis agonist | 0.071 0.021 CID_154699615 | CID_154699615 | |
| 0.048 | 0.075 | 0.085 | Nitric oxide donor | 0.085 0.018 CID_154699615 | CID_154699615 | |
| 0.027 | 0.055 | 0.088 | Antibiotic Aminoglycoside-like | 0.088 0.004 CID_154699615 | CID_154699615 | |
| 0.186 | 0.215 | 0.434 | Interleukin 2 agonist | 0.434 0.019 CID_154699615 | CID_154699615 | |
| 0.101 | 0.134 | 0.361 | Thrombolytic | 0.361 0.015 CID_154699615 | CID_154699615 | |
| 0.007 | 0.044 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 CID_154699615 | CID_154699615 | |
| 0.152 | 0.189 | 0.405 | Peptidyltransferase inhibitor | 0.405 0.006 CID_154699615 | CID_154699615 | |
| 0.045 | 0.084 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.017 CID_154699615 | CID_154699615 | |
| 0.066 | 0.114 | 0.165 | Transcription factor NF kappa B stimulant | 0.165 0.013 CID_154699615 | CID_154699615 | |
| 0.01 | 0.067 | 0.02 | Corticosteroid-like | 0.02 0.017 CID_154699615 | CID_154699615 | |
| 0.014 | 0.094 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 CID_154699615 | CID_154699615 | |
| 0.018 | 0.106 | 0.064 | Phosphorylase inhibitor | 0.064 0.023 CID_154699615 | CID_154699615 | |
| 0.025 | 0.113 | 0.051 | Microtubule stabilization | 0.051 0.026 CID_154699615 | CID_154699615 | |
| 0.104 | 0.202 | 0.327 | Hypolipemic | 0.327 0.041 CID_154699615 | CID_154699615 | |
| 0.05 | 0.155 | 0.103 | Falcipain 2 inhibitor | 0.103 0.05 CID_154699615 | CID_154699615 | |
| 0.052 | 0.16 | 0.105 | Falcipain inhibitor | 0.105 0.051 CID_154699615 | CID_154699615 | |
| 0.002 | 0.119 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 CID_154699615 | CID_154699615 | |
| 0.024 | 0.142 | 0.396 | Selectin antagonist | 0.396 0.003 CID_154699615 | CID_154699615 | |
| 0.019 | 0.179 | 0.117 | Protein 50S ribosomal subunit inhibitor | 0.117 0.01 CID_154699615 | CID_154699615 | |
| 0.004 | 0.237 | 0.033 | Squalene synthetase inhibitor | 0.033 0.022 CID_154699615 | CID_154699615 | |
| 0.03 | 0.288 | 0.121 | ATPase (Vacuolar H+) inhibitor | 0.121 0.019 CID_154699615 | CID_154699615 | |
| 0.085 | 0.367 | 0.27 | Angiogenesis inhibitor | 0.27 0.109 CID_154699615 | CID_154699615 | |
| 0.015 | 0.319 | 0.059 | DNA gyrase inhibitor | 0.059 0.05 CID_154699615 | CID_154699615 | |
| 0.011 | 0.473 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_154699615 | CID_154699615 | |
| 0.016 | 0.496 | 0.088 | Factor IXa inhibitor | 0.088 0.013 CID_154699615 | CID_154699615 | |
| 0.024 | 0.546 | 0.256 | Cell adhesion inhibitor | 0.256 0.014 CID_154699615 | CID_154699615 | |
| 0.012 | 0.572 | 0.126 | Cell adhesion molecule inhibitor | 0.126 0.022 CID_154699615 | CID_154699615 | |
| 0.015 | 0.598 | 0.232 | Anticoagulant | 0.232 0.043 CID_154699615 | CID_154699615 | |
| 0.042 | 0.632 | 0.429 | Immunomodulator | 0.429 0.036 CID_154699615 | CID_154699615 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |